Prostate cancer decisions — 2020

The Board denied service connection for prostate cancer due to exposure to herbicides, finding that the Veteran was not exposed to Agent Orange (AO) in Guam.

The Board has decided to remand the case due to incomplete compliance with the requirement for a radiation exposure claim, and new information is needed regarding the Veteran's dose of ionizing radiation in service.

The Veteran's appeal is remanded to determine if a higher rating for his ED, which is associated with his prostate cancer, is warranted.

The Board has remanded the case for further development, including verifying the Veteran's statements about temporary duty or visitation to Vietnam and investigating his service aboard the USS Constellation. The appeal is not about service connection.

The Board has denied the Veteran's claims for service connection for prostate cancer due to Agent Orange exposure, lymph node cancer associated with prostate cancer, vesicular tissue cancer associated with prostate cancer, and erectile dysfunction associated with prostate cancer. The denial is based on a lack of evidence showing in-service exposure to herbicide agents like Agent Orange.

The Board denied service connection for prostate cancer, finding that the evidence did not support a link between the Veteran's in-service exposure to ionizing radiation and his current condition.

The Board has remanded the issues of entitlement to service connection for obstructive sleep apnea and gastrointestinal disability (claimed as a stomach disability), and higher staged initial ratings for PTSD. The Veteran's claims are being returned to the AOJ for further development.,The issue of entitlement to service connection for skin disability, presumed due to herbicide agent exposure, is remanded. The AOJ must provide the Veteran with an appropriate VA examination and obtain a medical opinion regarding the etiology of his skin condition.,The Board has remanded the issue of higher staged initial ratings for PTSD. The Veteran's claims are being returned to the AOJ for further development.

The Veteran's claims for service connection are being remanded due to the need for further development, including verification of Agent Orange exposure and VA examinations.

The Board denied the Veteran's claim for service connection for residuals of prostate cancer, finding that there was no evidence to support a causal link between his service and the condition.

The Board denied service connection for prostate cancer, non-Hodgkin’s lymphoma, and memory loss as the evidence did not support a link to service.

The Veteran's appeal was dismissed due to his death, and the Board has no jurisdiction to adjudicate the merits of this appeal at this time.

The Board denied the Veteran's request to increase his disability rating for prostate cancer residuals from 20 percent to a higher level, and also denied his attempt to restore the 100 percent rating. The decision upheld the reduction of the rating.

The Board has remanded the case due to incomplete development regarding whether the Veteran's prostate cancer is aggravated by his service-connected hypertension.

The Veteran's prostate cancer residuals are rated at 60 percent, the highest rating available for voiding dysfunction. The Board found no evidence of renal dysfunction and denied a higher rating.

The Veteran's acquired psychiatric disorder (MDD and GAD) is granted as secondary to his service-connected back disability. His prostate cancer is denied due to lack of exposure to herbicides or other substances in service.

The Board denied the claim for service connection for the cause of the Veteran's death, finding that there was no evidence to support a causal relationship between any service-connected conditions and the Veteran's fatal cancers.

The Veteran's claim for service connection for unspecified depressive disorder is granted, effective July 5, 2018.,Service connection for sleep apnea is denied.,A rating in excess of 60 percent for prostate cancer residuals with voiding dysfunction is denied.,An initial rating in excess of 50 percent for unspecified depressive disorder is denied.,TDIU beginning July 5, 2018, is granted.

The Board has remanded the case due to a lack of consideration of medical literature submitted by the Veteran regarding his prostate cancer and exposure to asbestos and laundry cleaning chemicals.

The Veteran's prostate cancer and skin cancer are remanded for a VA examination to determine if they are related to his exposure at Camp Lejeune during service.

The Veteran's death was caused by prostate cancer, which is presumed to be related to his service in Thailand due to exposure to herbicide agents. The Board granted the claim for service connection for the cause of death.